Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
Eileen Morgan(Centre international de recherche sur le cancer), Melina Arnold(Roche (Switzerland)), Nicoleta Zenovia Antone(Institute of Oncology Prof. Dr. Ion Chiricuta), Julie R. Gralow(American Society of Clinical Oncology), Fátima Cardoso(Breast Cancer Alliance), Sabine Siesling(Netherlands Comprehensive Cancer Organisation), Serban Negoita(National Institutes of Health), Miriam Mutebi(Aga Khan University Hospital Nairobi), Paul Walsh, Ryan Woods, Richa Shah(Centre international de recherche sur le cancer), Isabelle Soerjomataram(Centre international de recherche sur le cancer), Karen A. Gelmon(University of British Columbia), Esmeralda Ramirez‐Peña(National Institutes of Health), Aude Bardot(Centre international de recherche sur le cancer), Lou Gonsalves(Connecticut Department of Public Health), Oliver Langselius(Centre international de recherche sur le cancer), Clara Frick(German Cancer Research Center), Colette O’Neill(National Cancer Registry), Hanna Fink(Centre international de recherche sur le cancer), Yaqi Su(Centre international de recherche sur le cancer), Jan F. Nygård(Cancer Registry of Norway)
Cited by 19
Related Papers
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
|CA A Cancer Journal for Clinicians|2021|112.4k
Current and future burden of breast cancer: Global statistics for 2020 and 2040
|The Breast|2022|3.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k